Climate change and global issues in allergy and immunology.

Climate change air pollution allergy asthma dust storms global warming greenhouse gases heat waves human health thunderstorms tropical storms vulnerable populations wildfires

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
12 2021
Historique:
received: 11 08 2021
revised: 12 10 2021
accepted: 18 10 2021
pubmed: 25 10 2021
medline: 22 12 2021
entrez: 24 10 2021
Statut: ppublish

Résumé

The steady increase in global temperatures, resulting from the combustion of fossil fuels and the accumulation of greenhouse gases (GHGs), continues to destabilize all ecosystems worldwide. Although annual emissions must be halved by 2030 and reach net zero by 2050 to limit some of the most catastrophic impacts associated with a warming planet, the world's efforts to curb GHG emissions fall short of the commitments made in the 2015 Paris Agreement. To this effect, July 2021 was recently declared the hottest month ever recorded in 142 years. The ramifications of these changes for global temperatures are complex and further promote outdoor air pollution, pollen exposure, and extreme weather events. Besides worsening respiratory health, air pollution promotes atopy and susceptibility to infections. The effects of GHGs on pollen affect the frequency and severity of asthma and allergic rhinitis. Changes in temperature, air pollution, and extreme weather events exert adverse multisystemic health effects and disproportionally affect disadvantaged and vulnerable populations. This review article is an update for allergists and immunologists about the health impacts of climate change that are already evident in our daily practices. It is also a call to action and advocacy, including to integrate climate change-related mitigation, education, and adaptation measures to protect our patients and avert further injury to our planet.

Identifiants

pubmed: 34688774
pii: S0091-6749(21)01622-5
doi: 10.1016/j.jaci.2021.10.011
pii:
doi:

Substances chimiques

Fossil Fuels 0
Greenhouse Gases 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1366-1377

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Susan E Pacheco (SE)

University of Texas Health Science Center, McGovern Medical School, Houston, Tex. Electronic address: Susan.E.Pacheco@uth.tmc.edu.

Guillermo Guidos-Fogelbach (G)

E.N.M H/SEPI, Instituto Politecnico Nacional, Mexico City, Mexico.

Isabella Annesi-Maesano (I)

Institute Desbrest of Epidemiology and Public Health, INSERM and Montpellier University, Montpellier, France.

Ruby Pawankar (R)

Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan.

Gennaro D' Amato (G)

Chairman Committee of World Allergy Organization on "Aerobiology, Climate Change, Biodiversity, and Allergy", Division of Respiratory Diseases and Allergy, High Specialty Hospital A. Cardarelli, Naples, Italy; School of Specialization in Respiratory Diseases, University of Naples, Federico II, Naples.

Patricia Latour-Staffeld (P)

Centro Avanzado De Alergia y Asma Santo Domingo, Santo Domingo, Dominican Republic; School of Medicine, Universidad Nacional Pedro Henriquez Ureña, Santo Domingo, Dominican Republic.

Marylin Urrutia-Pereira (M)

Pediatrics Department, Federal University of Pampa, Bagé, Rio Grande do Sul, Brazil.

Matthew J Kesic (MJ)

Campbell University Physician Assistant Program College of Pharmacy and Health Sciences, Campbell University, Buies Creek.

Michelle L Hernandez (ML)

Clinical Research Unit, Children's Research Institute, University of North Carolina School of Medicine, Chapel Hill, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH